CN104784405A - 一种用于治疗耳石症的药膏贴 - Google Patents
一种用于治疗耳石症的药膏贴 Download PDFInfo
- Publication number
- CN104784405A CN104784405A CN201510218369.4A CN201510218369A CN104784405A CN 104784405 A CN104784405 A CN 104784405A CN 201510218369 A CN201510218369 A CN 201510218369A CN 104784405 A CN104784405 A CN 104784405A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- plaster
- medical ointment
- ointment plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 13
- 229910021538 borax Inorganic materials 0.000 claims abstract description 10
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 10
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 201000010099 disease Diseases 0.000 claims description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 27
- 210000001265 otolithic membrane Anatomy 0.000 claims description 27
- 230000002842 otolith Effects 0.000 claims description 26
- 241000356847 Otolithes Species 0.000 claims description 25
- 239000002674 ointment Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000009286 sanguis draxonis Substances 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 5
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 5
- 239000007766 cera flava Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000000155 melt Substances 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 239000010703 silicon Substances 0.000 claims description 5
- 229940099259 vaseline Drugs 0.000 claims description 5
- 239000011787 zinc oxide Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000219357 Cactaceae Species 0.000 abstract 1
- 241001043298 Croton draco Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001106477 Paeoniaceae Species 0.000 abstract 1
- 241000095444 Populus davidiana Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 240000003152 Rhus chinensis Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 210000003128 head Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000003949 semicircular duct Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical group OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 241000218202 Coptis Species 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003027 ear inner Anatomy 0.000 description 2
- 210000000959 ear middle Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000758724 Schisandraceae Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047348 Vertigo positional Diseases 0.000 description 1
- 206010047466 Viral labyrinthitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000000691 benign paroxysmal positional nystagmus Diseases 0.000 description 1
- 208000001870 benign paroxysmal positional vertigo Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 210000003477 cochlea Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 150000004691 decahydrates Chemical class 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 206010033103 otosclerosis Diseases 0.000 description 1
- 231100000199 ototoxic Toxicity 0.000 description 1
- 230000002970 ototoxic effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种用于治疗耳石症的药膏贴,其是由按以下重量份数的中药原料制成的:黄连6-12份、鲜杨树皮8-10份、鸡血藤8-10份、硼砂5-7份、血竭5-6份、冬青叶6-8份、五倍子12-15份、白芍6-10份、仙人掌根5-8份、冰片8-10份。本发明药膏贴可具有清热燥湿,宣散风热,补血凉血,泻火解毒,通经活络,开窍醒神等功效,对耳石症有较好的疗效。
Description
技术领域
本发明涉及一种用于治疗耳石症的中药药物,具体地说是涉及一种用于治疗耳石症的药膏贴。
背景技术
耳石症又称为良性阵发性位置性眩晕,是指头部迅速运动至某一特定头位时出现的短暂阵发性发作的眩晕和眼震。正常情况下耳石是附着于耳石膜上的,当一些致病因素导致耳石脱离,这些脱落的耳石就会在内耳内被称作为内淋巴的液体里游动,当人体头位变化时,这些半规管亦随之发生位置变化,沉伏的耳石就会随着液体的流动而运动,从而刺激半规管毛细胞,导致机体发生强烈性眩晕,时间一般较短,数秒至数分钟,可周期性加重或缓解。病程时间长短不一。
耳石症的病因一般可分为两类,一类为原发性称之为耳石病,另一类为继发性,继发于梅尼埃病、突聋、病毒性迷路炎、内听道动脉缺血、偏头疼、头部外伤、中耳和内耳术后,人工耳蜗术后,耳毒性药物损害,耳硬化症,慢性中耳炎及颈性眩晕等,上述各种疾病导致了半规管的炎症或缺血损伤而致耳石脱落。
目前对耳石症的治疗多采用体位疗法,或服用一些前庭抑制剂如脑益嗪、非那根等,治疗效果均不甚理想。
发明内容
本发明的任务在于提供一种用于治疗耳石症的药膏贴,该外用药膏贴具有疗效确切,药物原料简单易得等优点。
其技术解决方案是:
一种用于治疗耳石症的药膏贴,其是由按以下重量份数的中药原料制成的:黄连6-12份、鲜杨树皮8-10份、鸡血藤8-10份、硼砂5-7份、血竭5-6份、冬青叶6-8份、五倍子12-15份、白芍6-10份、仙人掌根5-8份、冰片8-10份。
优选的,各中药原料的重量份配比是:黄连10份、鲜杨树皮8份、鸡血藤10份、硼砂6份、血竭6份、冬青叶8份、五倍子12份、白芍6份、仙人掌根6份、冰片8份。
上述用于治疗耳石症的药膏贴,其是采取下述步骤制备的:
a将上述重量份的中药原料分别粉碎成100-130目细度,然后混合均匀,得到粉剂;
b将矿物油30份和松香100份注入锅中,文火熔化,放入蜂蜡5-8份,再放入凡士林20份和氧化锌5份,搅拌均匀,然后加入步骤a得到的粉剂50-80份,边加边搅拌,保持文火,最后注入硅氮酮3份搅拌均匀,熬制成膏状;
c摊膏,制成药膏贴。
本发明的药理分析及效果如下:
本发明中的黄连属毛茛科、黄连属多年生草本植物,有清热燥湿,泻火解毒之功效。鲜杨树皮中含有丰富的杨树皮类脂,其是一种橙黄色脂溶性物质,由于其独有的天然生物学活性,在畜牧兽医、医药方面都有着广泛的应用前景,杨树皮的药用功效最早在《本草纲目》中有记载。鸡血藤为五味子科、大血藤科、菟丝子科、蝶形花科等多种植物的别称,具有补血行血,通经活络的功效。硼砂即四硼酸钠的十水合物,是非常重要的含硼矿物及硼化合物,有抑菌、抗惊厥及保护皮肤黏膜等作用,有毒。血竭为棕榈科植物麒麟竭果实渗出的树脂经加工制成,具有活血定痛,化瘀止血,生肌敛疮的功效。冬青叶又名四季青叶,叶含两种抑菌成分,其中之一是原儿茶酸,另含挥发油、黄酮类,治烫伤,溃疡久不愈合,闭塞性脉管炎,菌痢,外伤出血,冻瘃,皲裂等。五倍子性寒,味酸、涩,具有敛肺降火、涩肠止泻、敛汗止血、收湿敛疮等功效。白芍性凉,味苦酸,微寒,具有补血养血、平抑肝阳、柔肝止痛、敛阴止汗等功效。仙人掌根味苦,性寒,具有行气活血、清热解毒之功效。冰片具有开窍醒神、散郁火、消肿止痛的功效。
上述十味中药并用,可具有清热燥湿,宣散风热,补血凉血,泻火解毒,通经活络,开窍醒神等功效,对耳石症有较好的疗效。而且药膏贴为外用药,无毒副作用,并具有所需原料药种类较少,且简单易得,成本低等优点。
具体实施方式
下面结合实施例对本发明作进一步说明:
实施例1
称取黄连100克、鲜杨树皮80克、鸡血藤100克、硼砂60克、血竭60克、冬青叶80克、五倍子120克、白芍60克、仙人掌根60克、冰片80克。分别粉碎成100-130目细度,然后混合均匀,得到粉剂。
将矿物油300克和松香1000克注入锅中,文火熔化,放入蜂蜡60克,再放入凡士林200克和氧化锌50克,搅拌均匀,然后上述粉剂,边加边搅拌,保持文火,最后注入硅氮酮30克,搅拌均匀,熬制成膏状。
摊膏,制成药膏贴。
实施例2
称取黄连60克、鲜杨树皮80克、鸡血藤80克、硼砂70克、血竭50克、冬青叶60克、五倍子120克、白芍60克、仙人掌根80克、冰片100克。分别粉碎成100-130目细度,然后混合均匀,得到粉剂。
将矿物油300克和松香1000克注入锅中,文火熔化,放入蜂蜡60克,再放入凡士林200克和氧化锌50克,搅拌均匀,然后上述粉剂,边加边搅拌,保持文火,最后注入硅氮酮30克,搅拌均匀,熬制成膏状。
摊膏,制成药膏贴。
实施例3
称取黄连120克、鲜杨树皮100克、鸡血藤100克、硼砂50克、血竭60克、冬青叶80克、五倍子150克、白芍100克、仙人掌根50克、冰片80克。分别粉碎成100-130目细度,然后混合均匀,得到粉剂。
将矿物油300克和松香1000克注入锅中,文火熔化,放入蜂蜡60克,再放入凡士林200克和氧化锌50克,搅拌均匀,然后上述粉剂,边加边搅拌,保持文火,最后注入硅氮酮30克,搅拌均匀,熬制成膏状。
摊膏,制成药膏贴。
临床资料
1、基本资料
选取2013年1月-2014年6月就诊的耳石症患者100例,男性42例,女性58例,平均年龄45岁。全部病例均按耳石症临床诊断相关标准确定。该100例耳石症患者中,原发性耳石症患者32例;继发性耳石症患者68例,其中继发于内听道动脉缺血患者19例、继发于偏头疼患者12例、继发于头部外伤患者15例、继发于中耳和内耳术后患者16例,继发于颈性眩晕患者6例。
2、治疗方法
将上述实施例所得药膏贴,贴于患者颈部,且药膏贴的两边直至两耳根部,一日一贴,七日为一个疗程,上述100例患者均治疗一个疗程。
3、疗效判定
具体疗效分以下三级:治愈—耳石症症状全部消失;好转—耳石症症状明显减轻;无效—耳石症症状毫无消失。
4、疗效总结
具体疗效情况见表1。
表1
从表1中可看出,采用本发明药物治疗耳石症,治愈率达到91%,总有效率高达98%,治愈率及总有效率均比较高,治疗效果显著,值得更进一步临床推广。而且从表1中还可看出,本发明药物尤其适用于继发性耳石症患者的治疗,对继发性耳石症患者的总有效率高达100%。另外对上述治愈患者均进行半年后随访,发现仅有1例复发,再次复发的几率非常低。
Claims (3)
1.一种用于治疗耳石症的药膏贴,其特征在于是由按以下重量份数的中药原料制成的:黄连6-12份、鲜杨树皮8-10份、鸡血藤8-10份、硼砂5-7份、血竭5-6份、冬青叶6-8份、五倍子12-15份、白芍6-10份、仙人掌根5-8份、冰片8-10份。
2.根据权利要求1所述的用于治疗耳石症的药膏贴,其特征在于各中药原料的重量份配比是:黄连10份、鲜杨树皮8份、鸡血藤10份、硼砂6份、血竭6份、冬青叶8份、五倍子12份、白芍6份、仙人掌根6份、冰片8份。
3.根据权利要求1或2所述的用于治疗耳石症的药膏贴,其特征在于是采取下述步骤制备的:
a将上述重量份的中药原料分别粉碎成100-130目细度,然后混合均匀,得到粉剂;
b将矿物油30份和松香100份注入锅中,文火熔化,放入蜂蜡5-8份,再放入凡士林20份和氧化锌5份,搅拌均匀,然后加入步骤a得到的粉剂50-80份,边加边搅拌,保持文火,最后注入硅氮酮3份搅拌均匀,熬制成膏状;
c摊膏,制成药膏贴。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510218369.4A CN104784405A (zh) | 2015-05-04 | 2015-05-04 | 一种用于治疗耳石症的药膏贴 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510218369.4A CN104784405A (zh) | 2015-05-04 | 2015-05-04 | 一种用于治疗耳石症的药膏贴 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784405A true CN104784405A (zh) | 2015-07-22 |
Family
ID=53549899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510218369.4A Withdrawn CN104784405A (zh) | 2015-05-04 | 2015-05-04 | 一种用于治疗耳石症的药膏贴 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784405A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435110A (zh) * | 2015-12-24 | 2016-03-30 | 杨晓东 | 一种治疗类风湿性关节炎的药膏贴 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110166060A1 (en) * | 2008-05-19 | 2011-07-07 | Massachusettes Institute Of Technology | Tympanic membrane permeating ear drops and uses thereof |
| CN102258671A (zh) * | 2011-07-20 | 2011-11-30 | 燕翠萍 | 用于治疗痛风的药膏贴及其制备方法 |
-
2015
- 2015-05-04 CN CN201510218369.4A patent/CN104784405A/zh not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110166060A1 (en) * | 2008-05-19 | 2011-07-07 | Massachusettes Institute Of Technology | Tympanic membrane permeating ear drops and uses thereof |
| CN102258671A (zh) * | 2011-07-20 | 2011-11-30 | 燕翠萍 | 用于治疗痛风的药膏贴及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 李雪琴等: "益气聪明汤加减治疗位置性眩晕33例", 《陕西中医学院学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435110A (zh) * | 2015-12-24 | 2016-03-30 | 杨晓东 | 一种治疗类风湿性关节炎的药膏贴 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103599494B (zh) | 一种治疗颈椎病的外用中药 | |
| CN103070965B (zh) | 一种消肿止痛、活血通络的中药 | |
| KR20100079858A (ko) | 천연광물과 한약재를 주원료로 한 피부질환 치료용 외용제 | |
| CN103263529A (zh) | 一种治疗骨折的中药组合物 | |
| CN104784405A (zh) | 一种用于治疗耳石症的药膏贴 | |
| CN105902952A (zh) | 一种通脉暖骨药粉 | |
| CN102266546B (zh) | 治疗冻伤的外用中药制剂及制备方法 | |
| CN102228652B (zh) | 治疗慢性腹膜炎的中药组合物及其制备方法 | |
| CN104815286A (zh) | 一种治疗三叉神经痛的中药配方 | |
| CN114177231B (zh) | 一种退热的药物组合物、退热凝胶及制备方法 | |
| CN105267577B (zh) | 一种治疗流行性腮腺炎的贴膏及其制备方法 | |
| CN104623457B (zh) | 缩阴排毒祛斑凝胶剂及其制备方法 | |
| CN102552550A (zh) | 一种治疗脚气的中药组合物 | |
| CN105079206A (zh) | 一种具有止痛功效的中药组合物及其制备方法 | |
| CN105267516A (zh) | 一种用于皮肤表层局部麻醉的膏药 | |
| CN100998660B (zh) | 治疗椎动脉型颈椎病中药贴及其制备方法 | |
| CN105616653A (zh) | 一种治疗痱子的中药组合物 | |
| CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
| CN105194443A (zh) | 一种用于治疗小儿湿疹的中药组合物及其制备方法 | |
| CN106109802B (zh) | 一种治疗原发性痛经的中药组合物及其制备方法和用途 | |
| CN104740140B (zh) | 一种治疗烧烫伤的中药外用护理药物 | |
| CN103751499A (zh) | 一种治疗口腔溃疡的中药组合物 | |
| CN101934016A (zh) | 一种治疗关节炎的外用药及其含有矿物质的药膏贴 | |
| CN104825589A (zh) | 一种治疗耳石症的药物 | |
| CN104257852B (zh) | 一种治疗偏头痛的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150722 |
|
| WW01 | Invention patent application withdrawn after publication |